Air & Water Borne Diseases
Open Access

Severe Acute Respiratory Syndrome (SARS); SARS-associated coronavirus (SARS-CoV); Respiratory illness; Global public health emergency; Zoonotic disease; RNA virus; Angiotensin-converting; enzyme 2 (ACE2) receptor; Transmission; Public health measures

Introduction

Severe Acute Respiratory Syndrome, commonly known by its acronym SARS, emerged as a significant global health threat in the early 21st century, highlighting the interconnectedness of the modern world and the critical importance of global health surveillance [1]. Caused by a novel coronavirus, SARS-CoV, the syndrome first appeared in late 2002 in Guangdong province, China, and rapidly spread to various parts of the world, leading to a global outbreak in 2003 [2]. This outbreak resulted in considerable morbidity and mortality, causing widespread concern and prompting swift public health responses internationally [3]. The initial cases of SARS were linked to animal markets in Guangdong, suggesting a zoonotic origin. Coronaviruses are a large family of viruses known to cause illnesses ranging from the common cold to more severe diseases like Middle East Respiratory Syndrome (MERS) and SARS [4]. In the case of SARS, the virus is believed to have originated in bats and subsequently transmitted to humans through an intermediate host, possibly civet cats, which were sold in live animal markets [5]. From Guangdong, the virus spread to Hong Kong and subsequently to other countries through international travel. The highly contagious nature of SARS-CoV facilitated its rapid dissemination, particularly in densely populated urban centers [6]. Major outbreaks occurred in Hong Kong, Taiwan, Singapore, and Toronto, among other places. The World Health Organization (WHO) issued a global alert in March 2003, leading to increased efforts to contain the virus. The global response to the SARS outbreak was swift and coordinated [7]. Governments and health organizations implemented measures to identify and isolate infected individuals, trace and quarantine contacts, and restrict travel to affected areas. Public health campaigns emphasized the importance of hygiene and respiratory etiquette to reduce transmission. The WHO provided guidance and support to affected countries, facilitating international collaboration and information sharing [8].

The containment of SARS was achieved through a combination of aggressive public health interventions, enhanced surveillance, and the natural decline of the outbreak. By July 2003, the WHO declared the global SARS outbreak contained [9]. However, the episode underscored the potential for new infectious diseases to emerge and spread rapidly, necessitating ongoing vigilance and preparedness. Severe Acute Respiratory Syndrome (SARS) is a viral respiratory illness that emerged in the early 21st century, causing a significant global health crisis. This article delves into the origins, virology, epidemiology, clinical manifestations, diagnosis, treatment, prevention, and the global impact of SARS [10].

The SARS outbreak left a lasting impact on global public health. It exposed vulnerabilities in health systems and underscored the need for robust global health infrastructure capable of responding to emerging infectious diseases. The experience with SARS led to significant improvements in surveillance systems, laboratory capacities, and international collaboration. It also highlighted the critical importance of transparency and timely information sharing during public health crises.

In the years following the SARS outbreak, the world faced subsequent challenges with other emerging infectious diseases, such as MERS and, most notably, the COVID-19 pandemic caused by another novel coronavirus, SARS-CoV-2. The lessons learned from SARS informed the response to these subsequent outbreaks, emphasizing the importance of rapid detection, comprehensive contact tracing, and effective quarantine measures.

Origins and virology

Origins

SARS first emerged in November 2002 in the Guangdong province of southern China. The disease quickly spread to several countries, including Hong Kong, Vietnam, Singapore, Canada, and the United States, leading to a worldwide health alert. The initial outbreak was linked to the handling and consumption of certain exotic animals, such as civet cats, sold in live-animal markets. Genetic analysis later confirmed that the virus likely originated from bats and was transmitted to humans through an intermediate host, possibly the civet cat.

Virology

SARS is caused by the SARS-associated coronavirus (SARS-CoV), a member of the coronavirus family. Coronaviruses are enveloped RNA viruses characterized by their crown-like spikes on the viral surface. SARS-CoV belongs to the Beta coronavirus genus, which also includes Middle East Respiratory Syndrome coronavirus (MERS-CoV) and the novel coronavirus responsible for COVID-19 (SARS-CoV-2). The virus primarily targets the respiratory system, infecting the epithelial cells of the lungs.

Epidemiology

The SARS outbreak lasted from late 2002 until mid-2003, with over 8,000 reported cases and nearly 800 deaths across 26 countries. The outbreak had a significant impact in Asia, particularly in China and Hong Kong. The World Health Organization (WHO) declared SARS contained in July 2003, following extensive international public health measures. However, isolated cases continued to occur until 2004.

Transmission

SARS is primarily transmitted through respiratory droplets when an infected person coughs or sneezes. It can also spread through direct contact with contaminated surfaces or objects, followed by touching the face, especially the mouth, nose, or eyes. The virus can survive on surfaces for several hours, making fomite transmission a concern.

Clinical Manifestations

Symptoms

SARS typically begins with flu-like symptoms, including fever, chills, and muscle aches. Other common symptoms include headache, diarrhea, and general malaise. After a few days, the illness progresses to involve the lower respiratory tract, leading to symptoms such as:

Dry cough

Shortness of breath

Difficulty breathing

In severe cases, SARS can lead to pneumonia, acute respiratory distress syndrome (ARDS), and respiratory failure, necessitating mechanical ventilation.

Complications

The most severe complications of SARS include respiratory failure, liver damage, and heart failure. Older adults and individuals with underlying health conditions, such as diabetes or heart disease, are at higher risk of severe disease and mortality.

Diagnosis

Laboratory testing

Diagnosis of SARS is primarily based on clinical symptoms and epidemiological factors, such as travel history and contact with infected individuals. Laboratory confirmation is achieved through various methods, including:

Polymerase chain reaction (PCR): Detects viral RNA in respiratory secretions, blood, or stool samples.

Serology: Detects antibodies against SARS-CoV in blood samples, indicating past infection.

Viral culture: Isolates the virus from clinical specimens, though this is less commonly used due to biosafety concerns.

Imaging

Chest radiography and computed tomography (CT) scans often reveal pneumonia with ground-glass opacities or consolidation, which are typical findings in SARS patients.

Treatment

Supportive care

There is no specific antiviral treatment for SARS. Management primarily involves supportive care to relieve symptoms and maintain vital organ function. This includes:

Oxygen therapy: To improve oxygenation in patients with respiratory distress.

Mechanical ventilation: For severe cases with respiratory failure.

Fluids and electrolytes: To maintain hydration and electrolyte balance.

Antiviral and other therapies

During the SARS outbreak, various antiviral medications, corticosteroids, and other treatments were used experimentally. However, none proved definitively effective in controlled studies. Research continues into potential treatments, including monoclonal antibodies and novel antiviral agents.

Prevention

Infection control measures

Preventing the spread of SARS involves stringent infection control measures, including:

Isolation of Infected Patients: To prevent transmission to others.

Use of Personal Protective Equipment (PPE): Such as masks, gloves, gowns, and eye protection by healthcare workers.

Hand Hygiene: Frequent handwashing with soap and water or using alcohol-based hand sanitizers.

Environmental Cleaning: Regular disinfection of surfaces and objects in healthcare and community settings.

Travel Restrictions and Quarantine

During the SARS outbreak, travel restrictions and quarantine measures were implemented to control the spread of the virus. Screening at airports and other points of entry helped identify and isolate suspected cases.

Global impact

Economic and social effects

The SARS outbreak had significant economic and social impacts, particularly in the affected regions. Travel bans and reduced consumer confidence led to substantial losses in the tourism, hospitality, and retail sectors. Healthcare systems were strained, and the public's fear and uncertainty caused social disruption.

Lessons learned

The SARS epidemic highlighted the importance of global collaboration and swift public health responses to emerging infectious diseases. Key lessons learned include:

Rapid information sharing: Timely communication between countries and health organizations is crucial for controlling outbreaks.

Public health infrastructure: Strengthening healthcare systems and laboratory capacities is essential for early detection and response.

Research and development: Continued investment in research for vaccines, treatments, and diagnostic tools is vital for preparedness against future pandemics.

Conclusion

Severe Acute Respiratory Syndrome (SARS) was a wake-up call for the global health community, underscoring the potential threat posed by emerging infectious diseases. While the outbreak was contained, the experience gained has informed strategies for managing future pandemics. Enhanced surveillance, rapid response mechanisms, and international cooperation remain critical in preventing and mitigating the impact of similar infectious diseases in the future. Severe Acute Respiratory Syndrome serves as a stark reminder of the perpetual threat posed by emerging infectious diseases in a globally connected world. The SARS outbreak of 2002-2003 demonstrated both the potential for rapid viral spread and the effectiveness of coordinated global health responses. It catalyzed advancements in public health infrastructure and pandemic preparedness, shaping the global health landscape and informing responses to future health emergencies. Understanding the history and impact of SARS is crucial for ongoing efforts to prevent and mitigate the effects of future infectious disease outbreaks.

References

1. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J (2012) Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 7: 35797.

Indexed at, Google Scholar, Crossref

2. Tang JW (2009) the effect of environmental parameters on the survival of airborne infectious agents. J R Soc Interface 6: 737-746.

Indexed at, Google Scholar, Crossref

3. Peterson K, Novak D, Stradtman L, Wilson D, Couzens L (2015) Hospital respiratory protection practices in 6 U.S. states: a public health evaluation study. Am J Infect Control 43: 63-71.

Indexed at, Google Scholar, Crossref

4. Ganz AB, Beker NM (2019) Neuropathology and cognitive performance in self-reported cognitively healthy centenarians. Acta Neuropathol Commun 6: 64.

Indexed at, Google Scholar, Crossref

5. German MN, Walker MK (1988) the human locus coeruleus Computer reconstruction of cellular distribution. J Neurosci 8: 1776-1788.

Indexed at, Google Scholar, Crossref

6. Pereira LA, Loomis D, Conceição GM, Braga AL, Arcas RM, et al. (1998) Association between Air Pollution and Intrauterine Mortality in São Paulo, Brazil.Environmental Health Perspectives 106: 325-329.

Indexed at, Google Scholar, Crossref

7. Scoggins A, Kjellstrom T, Fisher G, Connor J, Gimson N (2004) Spatial Analysis of Annual Air Pollution and Mortality. Sci Total Environ 321: 71-85.

Indexed at, Google Scholar, Crossref

8. Xu X, Wang L (1993) Association of Indoor and Outdoor Particulate Level with Chronic Respiratory Disease. Am Rev Respir Dis 148: 1516-1522.

Indexed at, Google Scholar, Crossref

9. Gauderman WJ (2015)Association of improved air quality with lung development in children. New Engl J Med 372: 905-913.

Indexed at, Google Scholar, Crossref

10. Di Q. (2017)Air pollution and mortality in the medicare population. New Engl J Med 376: 2513-2522.

Indexed at, Google Scholar, Crossref